Boosting RSV Immunization Uptake in The Netherlands: (Expectant) Mothers and Healthcare Professionals' Insights on Different Strategies.

ABSTRACT: Background: Respiratory syncytial virus (RSV) is a major cause of infant respiratory illness, leading to significant hospitalizations. Two preventive strategies exist: maternal vaccination and a long-acting monoclonal antibody for neonates. In The Netherlands, neonatal immunization is planned to start from autumn 2025 onward, contingent on acceptance by parents and healthcare professionals. Maternal vaccination is already available at own costs. Understanding acceptance, perceptions, and barriers is critical for effective implementation. This study explores these factors to inform strategies for optimal uptake. Methods: This mixed-method study involved semi-structured online interviews with 21 (expectant) mothers (EMs) and 32 healthcare professionals (HCPs) involved in matern

SUBMITTER: van Leeuwen L 

PROVIDER: S-EPMC12567916 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature